Executive Summary – Final MSSP Benchmarking Rule
This document summarizes the Centers for Medicare & Medicaid Services's (CMS's) long awaited rule finalizing changes to the Medicare Shared Savings Program (MSSP) benchmark rebasing methodology, published in the June 10, 2016, Federal Register.
HFMA Comments on CMS’s FY17 IPPS Proposed Rule (CMS 1665-P)
HFMA submitted a comment letter to CMS on the FY17 Medicare Program Proposed Rule published in the April 27, 2016, Federal Register.
HFMA Comments on CMS’s Part B Drug Payment Model Proposed Rule
This document contains HFMA's comments to CMS on the proposed changes to Medicare’s reimbursement methodology for separately payable Part B drugs.
Proposed Rule: Medicare Inpatient Hospital Operating and Capital Payment for Fiscal Year 2017
This document summarizes proposed payment rate updates to hospitals under the inpatient prospective payment system for fiscal year 2017.
Executive Summary: CMS 2017 IPPS Proposed Rule
This document provides an overview of the key financial and operating impacts of the FY17 IPPS proposed rule.
Summary of CMS’s Comprehensive Primary Care Plus (CPC+) Model
This document summarizes important details of CMS's Comprehensive Primary Care Plus (CPC+) model.
Ask the Expert: Payers Linking Cancellations of Separate Contracts
How can providers respond when payers threaten to terminate a Medicare Advantage contract if the provider terminates their separate commercial contract?
HFMA Comments on CMS’s Proposed Changes to the Medicare Shared Savings Program
HFMA submitted a comment letter to CMS on the proposed changes to the Medicare Shared Savings Program (MSSP) benchmarking and trending methodologies published in the February 3, 2016, Federal Register.
Medicare Overpayments Final Rule Fact Sheet
This fact sheet summarizes the final rule published by CMS requiring providers and suppliers receiving funds under the Medicare program to report and return overpayments.
Medicare Program; Part B Drug Payment Model Summary of Proposed Rule
This document summarizes the important details of CMS's proposal to test a new payment model called the Part B Drug Payment Model.